Buy & Sell Smith & Nephew plc (SNN) – Smith & Nephew plc Price Today
Aura AI Summary
Key Stats
- $12.94BMarket Cap
- HealthSector
- -17.99%3M Drawdown
- $15.71BEnterprise Value
- 2.58%Dividend Yield
- 119 daysTypical Hold Time
Smith & Nephew plc (SNN) is currently valued at a market capitalization of $12.94B, with an enterprise value of $15.71B. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $27.97 and a high of $38.7, highlighting its annual price range. Over the past three months, Smith & Nephew plc has recorded a drawdown of -17.99%, reflecting recent price volatility. Smith & Nephew plc offers a dividend yield of 2.58%, with the most recent dividend of $0.48 paid on 27 Mar 26. On average, investors hold Smith & Nephew plc for approximately 119 days, indicating typical investor behavior on the platform.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Most Recent News
Earned media drives 84% of AI citations, dominating over paid content in ChatGPT, Claude, and Gemini.
A study by Muck Rack analyzing over 25 million links reveals that earned media accounts for 84% of AI citations across ChatGPT, Claude, and Gemini, with journalism alone making up 27%. Paid and advertorial content represents only 0.3% of citations. T...
Incannex Healthcare wins award for innovative drug IHL-42X treating obstructive sleep apnea.
Incannex Healthcare has been recognized by MedTech Breakthrough with the "Best New Technology Solution for Drug Development" award for its lead drug candidate IHL-42X, an oral combination therapy for obstructive sleep apnea (OSA). IHL-42X combines dr...
Fredonia expands El Dorado–Monserrat gold-silver district by 50%, acquiring 11,754 hectares from Pan American Silver.
Fredonia Mining Inc. has acquired approximately 11,754 hectares of mineral properties from a Pan American Silver subsidiary, expanding its El Dorado–Monserrat (EDM) gold-silver project in Argentina to about 33,500 hectares—a 50% increase. This acquis...